SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Matinas BioPharma Hldgs Q1 EPS $(0.030), Inline

Matinas BioPharma Hldgs (NYSE:MTNB) reported quarterly losses of $(0.030) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.040) per share from the same period last

Benzinga · 05/11/2020 20:25

Matinas BioPharma Hldgs (NYSE:MTNB) reported quarterly losses of $(0.030) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.040) per share from the same period last year.